Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ecSeq Bioinformatics
    Senior Member
    • May 2012
    • 499

    #1

    Large scale cancer RNA-Seq study - Loss of poising causes cell dedifferentiation

    Large scale cancer RNA-Seq study - Loss of poising causes cell dedifferentiation

    Cell de-differentiation is an important step towards tumor generation. A group in Leipzig shows upregulation of hundreds of developmental genes, and link that to loss of chromatin poising. They show that this effect can be seen in virtually all cancers. This leads them to the hypothesis that loss of poising is what causes cell dedifferentiation.
    More than 5k samples were analyzed in this study and the effect can be seen in 90% of the samples.

    Stephan H Bernhart , Helene Kretzmer , Frank Jühling , Peter F Stadler , Steve Hoffmann: 'Disturbance of poised chromatin coincides with increased expression of developmental genes in cancer.', bioRxiv, 2015 - doi: http://dx.doi.org/10.1101/017251

    Link to paper
    ecSeq Bioinformatics is Europe’s leading provider of hands-on bioinformatics workshops and professional data analysis in the field of Next-Generation Sequencing (NGS).

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...